| 英文别名 |
Prostaglandin E2;(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate;7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid;PGE2;Prosta-5,13-diene-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E15S)-;Dinoprostone;PGE2 (Prostaglandin E2);Prostaglandin E2 Lipid Maps MS Standard;(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid;Cervidil;Cervidil(R);Cerviprost;l-pge2;MCH (human,mouse,rat);Prepidil;Propess;Prostenon;prostin;prostine2;(5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid;(5Z,11a,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;Dinoprostone (prostaglandin E2);Prostin E2;Minprositin E2;Minprostin E2;Dinoproston;(15S)-Prostaglandin E2;Prostarmon E;Dinoprostonum;l-Prostaglandin E2;Dinoprostona;PGE2alpha;Prostaglandin E2alpha;Dinoprostonum [INN-Latin];Dinoprostona [INN-Spanish];Prostaglandin E;(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-hepte;(E,Z)-(1R,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid;(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid;Dinoprostone, United States Pharmacopeia (USP) Reference Standard;BRD-K26521938-001-04-9;Glandin-E2;DINOPROSTONE (USP IMPURITY);(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-o xo-prosta-5,13-dien-1oic acid;DINOPROSTONE (USP MONOGRAPH);(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate;Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-;DINOPROSTONE (EP MONOGRAPH);CCG-208256;HMS1989K12;Dinoprostone [USAN:USP:INN:BAN:JAN];NS00009026;ALPROSTADIL IMPURITY G (EP IMPURITY);DINOPROSTONE [VANDF];LMFA03010003;(Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid;GTPL1916;NSC 165560;Prostaglandin E2, >=93% (HPLC), synthetic;EN300-22411484;Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-;(Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid;HMS1791K12;prosta-glandin e2;DINOPROSTONE [USAN];HMS3648F07;NSC-196514;Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo-;P2E;[3H]-PGE2;HMS2089D17;(5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid;DINOPROSTONE (MART.);(5Z,13E)-(15S)-11alpha15-Dihydroxy-9-oxoprost-13-enoate;A823207;CHEBI:15551;PGE(2);(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid;C20H32O5;Prostglandin E2;SR-05000001459-1;C00584;DTXCID002947;AMY30102;(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid;Prostin E2 (TN);NSC 196514;[3H]PGE2;[3H]prostaglandin E2;Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-;NSC196514;DTXSID4022947;S... |
![[亮氨酸15]-胃泌素 I 人](http://struc.chem960.com/strucimg/39100/cnpyobwfzmsuhufh4sr40aee.png)
